EGFR mutations are generally associated with a subset of lung adenocarcinomas, particularly in East Asian populations, non-smokers, and females, while such mutations are not typically observed in primary pancreatic malignancies. The gene discussed is EGFR; the disease is lung adenocarcinoma.